Wayne Winegarden Discusses Prescription Drug Prices  

Scripps National News | Wayne Winegarden
February 18, 2022

Watch PRI’s Wayne Winegarden, director of our Center for Medical Economics and Innovation, discuss efforts by the Federal Trade Commission to considering ordering large pharmacy benefits managers to study the competitive impact of contractual provisions, reimbursement adjustments, and other practices affecting drug prices.

Read more. . .

Stalled in D.C., the Single-Payer Fantasy Makes Its Way to Blue States 

National Review | Sally C. Pipes
February 21, 2022

Single-payer advocates persist in the belief that their cause is not only a moral imperative but also popular. Their rhetoric is seductive. Health care is a right, they argue. A wealthy country such as ours should be able to provide universal health coverage to all its citizens, just as other developed nations do.

But single-payer health care’s track record is disastrous.
 

What science says about the future of COVID-19

Genetic Literacy Project | Henry Miller
February 15, 2022

With pandemic fatigue becoming more intense, there is increasing speculation about when the SARS-CoV-2 virus, which causes COVID-19, might become “endemic” – a time when outbreaks will be more modest and manageable and we can “coexist” with the virus.

Read more. . .

COVID-19 tests come too late

Washington Examiner | Sally Pipes
February 21, 2022

The public desperately needed tests last month — when omicron was infecting 800,000 people each day . The Biden administration’s plan was too little, too late. But that’s simply par for the government course.

Read more. . .